Evidence map›Paper›PMID 32898668›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2020

Post-vaccine rotavirus genotype distribution in Nairobi County, Kenya.

Joshua Ndung'u Gikonyo, Betty Mbatia, Patrick W Okanya, George F O Obiero, Carlene Sang, Duncan Steele, James Nyangao

Abstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joshua Ndung'u GikonyoDepartment of Biochemistry and Biotechnology, The Technical University of Kenya (TU-K), PO Box 52428-00200, Nairobi, Kenya. Electronic address: jgikonyo@tukenya.ac.ke.
Betty MbatiaSchool of Pharmacy and Health Sciences, United States International University (USIU) - Africa, PO Box 14634-00800, Nairobi, Kenya. Electronic address: bembatia@usiu.ac.ke.
Patrick W OkanyaDepartment of Biochemistry and Biotechnology, The Technical University of Kenya (TU-K), PO Box 52428-00200, Nairobi, Kenya. Electronic address: okanyap@tukenya.ac.ke.
George F O ObieroDepartment of Biochemistry and Biotechnology, The Technical University of Kenya (TU-K), PO Box 52428-00200, Nairobi, Kenya. Electronic address: georgef.obiero@tukenya.ac.ke.
Carlene SangKenya Medical Research Institute (KEMRI), PO Box 43640-00100, Nairobi, Kenya. Electronic address: sangcarlene@kemri.org.
Duncan SteeleEnteric and Diarrhoeal Diseases, Global Health Bill and Melinda Gates Foundation PO Box 23350, Seattle, WA98102, USA. Electronic address: duncan.steele@gatesfoundation.org.
James NyangaoKenya Medical Research Institute (KEMRI), PO Box 43640-00100, Nairobi, Kenya. Electronic address: jnyangao@kemri.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRotaviruses are primary etiological agents of gastroenteritis in young children. In Kenya, G1P8 monovalent vaccine (Rotarix) was introduced in July 2014 for mandatory vaccination of all newborns at 6 and 10 weeks of age. Since then, no studies have been done to identify the rotavirus genotypes circulating in Nairobi County, Kenya, following the vaccine introduction, hence the post-vaccine genotype distribution is not known.

objectivesThe aim of this study was to determine the post-vaccine occurrence of rotavirus genotypes in children <5 years of age in Nairobi County, Kenya.

methodsStool samples were collected from children presenting with diarrhea for whom the vaccination status was card-confirmed. Fecal samples were analyzed for rotavirus antigen using a commercial enzyme immunoassay (EIA) kit, followed by characterization by polyacrylamide gel electrophoresis, RT-PCR, and nested PCR genotyping, targeting the most medically important genotypes.

resultsThe strains observed included G1P[8] (38.8%), G9P[8] (20.4%), G2P[4] (12.2%), G3[P4] (6.1%), G2P[6] (4.1%), and G9P[6] (4.1%). Mixed genotype constellations G3P[4][8] were also detected (4.1%). Remarkably, an increased prevalence of G2 genotypes was observed, revealing a change in genetic diversity of rotavirus strains. While the dominance of G1P[8] decreased after vaccination, an upsurge in G2P[4] (12.2%) and G9P[8] (20.4%) was observed. Additionally, G3[P4] (6.1%) and G2P[6] (4.1%) prevalence increased over the 3 years of study.

conclusionsThe results inform the need for robust longitudinal surveillance and epidemiological studies to assess the long-term interaction between rotavirus vaccine and strain ecology.

Indexed as

Child, PreschoolDiarrheaFecesFemaleGastroenteritisGenotypeHumansInfantInfant, NewbornKenyaMalePhylogenyPrevalenceRotavirusRotavirus InfectionsRotavirus VaccinesRIX4414 vaccineRotavirus VaccinesVaccines, AttenuatedGastroenteritisGenotypesRotarixRotavirusVaccine

Identifiers

PMID32898668
PMCPMC7670220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.